Results 41 to 50 of about 2,682 (167)

Small Molecule Fluorescent Ligands for the Atypical Chemokine Receptor 3 (ACKR3)

open access: yes, 2023
The atypical chemokine receptor 3 (ACKR3) is a receptor that induces cancer progression and metastasis in multiple cell types. Therefore, new chemical tools are required to study the role of ACKR3 in cancer and other diseases.
Barrie Kellam (1280532)   +12 more
core   +1 more source

CENPF Promotes EMT in Non-small Cell Lung Cancer by Up-regulating ACKR3/CXCR7

open access: yesZhongliu Fangzhi Yanjiu, 2022
Objective To investigate the relationship between the expression of CENPF in NSCLC adenocarcinoma (LUAD) and the clinical prognosis of patients and its effect on the metastasis of lung adenocarcinoma cells. Methods The expression of CENPF in LUAD and its
GU Tong   +6 more
doaj   +1 more source

From Insight to Modulation of CXCR4 and ACKR3 (CXCR7) Function [PDF]

open access: yesMolecular Pharmacology, 2019
Chemokine receptors CXCR4 and atypical chemokine receptor 3 (ACKR3/CXCR7) are highly expressed in a range of tumors. Yet, their role in cancer progression is not well understood. This minireview series encompasses seven comprehensive reviews focusing on modulators (small molecules, pepducins, antibodies), structural aspects, spatio-temporal signaling ...
Smit, Martine J.   +1 more
openaire   +3 more sources

D-dopachrome tautomerase contributes to lung epithelial repair via atypical chemokine receptor 3-dependent Akt signaling

open access: yesEBioMedicine, 2021
Background: Emphysematous COPD is characterized by aberrant alveolar repair. Macrophage migration inhibitory factor (MIF) contributes to alveolar repair, but for its structural and functional homolog D-dopachrome tautomerase (DDT) this is unknown.
Shanshan Song   +11 more
doaj   +1 more source

Circulating hsa_circ_0072309, acting via the miR‐100/ACKR3 pathway, maybe a potential biomarker for the diagnosis, prognosis, and treatment of brain metastasis from non‐small‐cell lung cancer

open access: yesCancer Medicine, 2023
Background One of the main causes of lung cancer‐related death is brain metastasis (BM). Finding early indicators of BM derived from lung cancer is crucial.
Xiao‐Qiang Zhang   +2 more
doaj   +1 more source

Structure–Activity Relationship Study of Cyclic Pentapeptide Ligands for Atypical Chemokine Receptor 3 (ACKR3)

open access: yes, 2018
The atypical chemokine receptor 3 (ACKR3)/CXC chemokine receptor 7 (CXCR7) recognizes stromal cell-derived factor 1 (SDF-1)/CXCL12 and is involved in a number of physiological and pathological processes.
Hiroaki Ohno (1457971)   +9 more
core   +3 more sources

α1‐Adrenergic Receptors Function Within Hetero‐Oligomeric Complexes With Atypical Chemokine Receptor 3 and Chemokine (C‐X‐C motif) Receptor 4 in Vascular Smooth Muscle Cells

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundRecently, we provided evidence that α1‐adrenergic receptors (ARs) in vascular smooth muscle are regulated by chemokine (C‐X‐C motif) receptor (CXCR) 4 and atypical chemokine receptor 3 (ACKR3). While we showed that CXCR4 controls α1‐ARs through
Lauren J. Albee   +7 more
doaj   +1 more source

The atypical chemokine receptor 3 interacts with Connexin 43 inhibiting astrocytic gap junctional intercellular communication

open access: yesNature Communications, 2020
The atypical chemokine receptor 3 (ACKR3) is known to regulate cell migration, but the underlying mechanisms are unclear. Here, the authors show, from an interactome analysis, ACKR3 association with the gap junction protein Connexin 43 in vivo and ACKR3 ...
Amos Fumagalli   +15 more
doaj   +1 more source

GPR182 and ACKR3 expression in the spleen.

open access: yes, 2023
(A) Confocal images showing GPR182 (mCherry, red) colocalization with CD31+ vessels (green) in a cleared spleen (ACT-ECT) (scale bar = 20 μm). (B) Flow cytometry analysis on sorted GPR182-positive spleen endothelial cells stained for ICAM2, Meca32, and ...
Antal Rot (253362)   +8 more
core   +1 more source

Research progress on the atypical chemokine receptor ACKR3 in cancer

open access: yesXin yixue
Atypical chemokine receptor 3 (ACKR3), also known as CXC chemokine receptor 7 (CXCR7), has attracted increasing attention for its regulatory roles in the tumor microenvironment.
Pan SUN, Lei XU, Juan YANG
doaj   +1 more source

Home - About - Disclaimer - Privacy